Application 761342

Type
BLA
Sponsor
JANSSEN BIOTECH

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761342Talveytalquetamab-tgvs351(a)Rx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TALVEYTALQUETAMAB-TGVSINJECTABLE;INJECTION3MG/1.5ML(2MG/ML)NoNo
002TALVEYTALQUETAMAB-TGVSINJECTABLE;INJECTION40MG/MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TALVEYTALQUETAMABJanssen Biotech, Inc.9001355e-003d-4d4e-b4ce-337e0fd149522025-10-08Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761342

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85851SUPPL 2026-05-08
85293SUPPL 2026-03-09
83658SUPPL 2025-10-03
83654SUPPL 2025-10-03
83653SUPPL 2025-10-03
83161SUPPL 2025-08-20
80486SUPPL 2024-12-03
78979SUPPL 2024-07-05
77589SUPPL 2024-02-21
76656SUPPL 2023-11-24
75589ORIG 2023-09-28
75357ORIG 2023-09-07
75026ORIG 2023-08-10
75025ORIG 2023-08-10